Company intelligence / Profile preview

PreviPharma

Mannheim, Baden-Württemberg, Germanyprevipharma.com ↗

Ownership: Private
Employees: ~34
Development stage: Preclinical

Overview

PreviPharma is a leading research and consulting partner for the plasma fractionation industry. The company supports clients across the entire R&D supply chain with specialized knowledge, state-of-the-art laboratory facilities, and strategic partnerships. It has 6 preclinical assets and a strong patent portfolio but does not appear to have clinical-stage programs of its own[2].

Therapeutic areas: Hematology
Modalities: Protein therapyPlasma-derived therapeutics
Industry: Consulting

Partnerships

Extensive network of qualified scientific and clinical research partners

Beyond the preview

Go deeper on PreviPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreviPharma.

Explore the full profile